의료용 로봇 시스템 시장 : 제품별, 전개 방식별, 최종사용자별, 지역별(2025-2033년)

The global medical robotic systems market size reached USD 22.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 95.7 Billion by 2033, exhibiting a growth rate (CAGR) of 16.53% during 2025-2033. Technological innovations, the rising demand for minimally invasive surgeries, the surging prevalence of chronic diseases, and investment in healthcare are primarily driving the market growth.

Medical robotic systems include robots that are utilized in the healthcare industry for surgical interventions and rehabilitation. Typically, these systems consist of mechanical arms with attached surgical instruments, and an installed camera. The most commonly used robotic systems include computer-controlled electromechanical devices called telemanipulators, which use the actions of the surgeon on one side to control the effector on the other side. These systems provide advanced visualization functionalities using HD cameras that provide surgeons with a detailed view of the concerned area, illustrated up to microscopic structures. Besides this, the robotic systems also offer relatively improved technical dexterity as they can rotate 360 degrees with superior maneuverability. Since they enable surgeons to reach hard-to-access areas in an efficient manner, they are extensively used as a crucial component in remotely controlled, minimally invasive procedures.

Medical Robotic Systems Market Trends:

The market is majorly driven by the increasing demand for minimally invasive surgeries (MIS). This can be attributed to the escalating preference for smaller incisions, fewer cuts, decreased scarring, reduced pain, improved safety, and faster recovery periods that are associated with MIS across the surgical domain. In line with this, the rising geriatric population and the continual technological advancements in novel surgical modalities are propelling the market growth across the globe. The market is further driven by the growing funding for research and development (R&D) activities focusing on medical robotics and the expanding healthcare expenditure. Some of the other factors contributing to the product demand include continual technological advancements, the augmenting need for automation in the healthcare industry, a considerable rise in the cases of trauma injuries, and the rapidly expanding medical tourism sector.

Key Market Segmentation:

Breakup by Product:

• Surgical Robots
• Orthopedic Surgical Robots
• Neurosurgical Robotic Systems
• Laparoscopy Robotic Systems
• Steerable Robotic Catheters
• Rehabilitation Robots
• Assistive Robots
• Prosthetics
• Orthotics
• Therapeutic Robots
• Exoskeleton Robotic Systems
• Noninvasive Radiosurgery Robots
• TrueBeam STx Radiosurgery System
• CyberKnife Robotic Radiosurgery System
• Gamma Knife Perfexion Radiosurgery System
• Hospital and Pharmacy Robots
• Telemedicine Robots
• I.V. Robots
• Cart Transportation Robots
• Emergency Response Robotic Systems

Breakup by Deployment Mode:

• On-premises
• Cloud-based

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Auris Health Inc. (Johnson & Johnson), DENSO Corporation, Intuitive Surgical Inc., iRobot Corporation, Medtronic plc, Omnicell Inc., Renishaw plc, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Titan Medical Inc. and Zimmer Biomet.

Key Questions Answered in This Report

• 1.What was the size of the global medical robotic systems market in 2024?
• 2.What is the expected growth rate of the global medical robotic systems market during 2025-2033?
• 3.What are the key factors driving the global medical robotic systems market?
• 4.What has been the impact of COVID-19 on the global medical robotic systems market?
• 5.What is the breakup of the global medical robotic systems market based on the product?
• 6.What are the key regions in the global medical robotic systems market?
• 7.Who are the key players/companies in the global medical robotic systems market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Robotic Systems Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Surgical Robots
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Orthopedic Surgical Robots
    • 6.1.2.2 Neurosurgical Robotic Systems
    • 6.1.2.3 Laparoscopy Robotic Systems
    • 6.1.2.4 Steerable Robotic Catheters
  • 6.1.3 Market Forecast
• 6.2 Rehabilitation Robots
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Assistive Robots
    • 6.2.2.2 Prosthetics
    • 6.2.2.3 Orthotics
    • 6.2.2.4 Therapeutic Robots
    • 6.2.2.5 Exoskeleton Robotic Systems
  • 6.2.3 Market Forecast
• 6.3 Noninvasive Radiosurgery Robots
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 TrueBeam STx Radiosurgery System
    • 6.3.2.2 CyberKnife Robotic Radiosurgery System
    • 6.3.2.3 Gamma Knife Perfexion Radiosurgery System
  • 6.3.3 Market Forecast
• 6.4 Hospital and Pharmacy Robots
  • 6.4.1 Market Trends
  • 6.4.2 Key Segments
    • 6.4.2.1 Telemedicine Robots
    • 6.4.2.2 I.V. Robots
    • 6.4.2.3 Cart Transportation Robots
  • 6.4.3 Market Forecast
• 6.5 Emergency Response Robotic Systems
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Deployment Mode

• 7.1 On-premises
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cloud-based
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Rehabilitation Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Accuray Incorporated
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Auris Health Inc. (Johnson & Johnson)
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 DENSO Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Intuitive Surgical Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 iRobot Corporation
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Medtronic plc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Omnicell Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Renishaw plc
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Siemens Healthineers AG (Siemens AG)
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Stryker Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Titan Medical Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Zimmer Biomet
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis